Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.

De Hert, Marc, Detraux, Johan, van Winkel, Ruud, Yu, Weiping, Correll, Christoph U.·2012·Nature Reviews Endocrinology

DOI 10.1038/nrendo.2011.156

Cited by (1,000)

Items 801–900 of 1,000

Effets métaboliques indésirables des antipsychotiques
Bruno Fève · 2013 · Obésité
Greater Arterial Stiffness in Children with or without Second-generation Antipsychotic Treatment for Mental Health Disorders: Rigidité Artérielle Plus Importante Chez Les Enfants Avec ou Sans Traitement Par Antipsychotiques de la Deuxième Génération Pour des Troubles de Santé Mentale
Amanda M. Henderson, Nazrul Islam, George G.S. Sandor, Constadina Panagiotopoulos, Angela M. Devlin · 2020 · The Canadian Journal of Psychiatry
Dilemma in Treating Clozapine-induced Obsessive-compulsive Symptoms in a Patient with Schizophrenia
Kah Kheng Goh, Yi-Hang Chiu, Winston W. Shen, Eng‐Kung Yeh · 2013 · Journal of Experimental & Clinical Medicine
The 4th Schizophrenia International Research Society Conference, 5–9 April 2014, Florence, Italy: A summary of topics and trends
Olukayode Abayomi, Davide Amato, C. C. Bailey, Byron K.Y. Bitanihirwe, Lynneice Bowen, Shimon Burshtein, Alexis E. Cullen, Montserrat Fusté, Ana Paula Herrmann, Babak Khodaie et al. · 2014 · Schizophrenia Research
Association of genetic risk scores with body mass index in Swiss psychiatric cohorts
Núria Saigí-Morgui, Frederik Vandenberghe, Aurélie Delacrétaz, Lina Quteineh, Mehdi Gholam‐Rezaee, Jean‐Michel Aubry, Armin von Gunten, Zoltán Kutalik, Philippe Conus, Chin B. Eap · 2016 · Pharmacogenetics and Genomics
A case of severe hypertriglyceridemia-induced acute pancreatitis
Megumi Yoshida, Yuka Kuwahara, Yasuhiro Kimura, Taikan Nanao, You Sugawara, Hideo Nishizawa · 2015 · Journal of the Japanese Society of Intensive Care Medicine
Antenatal antipsychotic exposure induces multigenerational and gender-specific programming of adiposity and glucose tolerance in adult mouse offspring
Émilie Courty, Ponny Gobalakichenane, Marie Garcia, Adeline Muscat, C. Kazakian, Tatiana Ledent, Marthe Moldes, Bertrand Blondeau, Delphine Mitanchez, Marion Buyse et al. · 2017 · Diabetes & Metabolism
Joining the debate around psychiatric medication
Philip Houghton · 2016 · Clinical Psychology Forum
Treatment of Risperidone-Associated Hyperprolactinemia With Aripiprazole
Omar A. Mazher, Eleni Maneta, William C. Hall · 2018 · Journal of Clinical Psychopharmacology
Continuation of structure–activity relationship study of novel benzamide derivatives as potential antipsychotics
Mingshuo Xu, Shuang Guo, Feipu Yang, Yu Wang, Chunhui Wu, Xiangrui Jiang, Qingjie Zhao, Wei-Ming Chen, Guanghui Tian, Fuqiang Zhu et al. · 2019 · Archiv der Pharmazie
History of Suicide Attempt and Clozapine Treatment in Veterans With Schizophrenia or Schizoaffective Disorder
Gregory H. Jones, Brian G. Mitchell, Jared D. Bernard, Annette M. Walder, Olaoluwa O. Okusaga · 2022 · The Primary Care Companion For CNS Disorders
Perfil metabólico y factores asociados en pacientes con esquizofrenia bajo tratamiento con antipsicóticos que acuden a consulta externa en el Instituto Nacional de Salud Mental (Perú).
Miguel Ricapa-Guerrero, Luis B. Guimas, Ray Ticse · 2017 · Revista de Neuro-Psiquiatría
Metabolic screening for patients with second-generation antipsychotic medication: A population-based study from 2004 to 2016
Edwin Ho Ming Lee, Christy Lai Ming Hui, Eunice Y.L. Law, Sherry Kit Wa Chan, Wing Chung Chang, Sherry Kit Wa Chan, Eric Yu Hai Chen · 2018 · Schizophrenia Research
Risk of bias in observational studies of interventions: the case of antipsychotic-induced diabetes
Fernando Rico‐Villademoros, Elena Pita Calandre · 2016 · The Lancet Psychiatry
Probiotic supplements reduce antipsychotic-induced metabolic disturbances in drug-naïve first-episode schizophrenia
Dongyu Kang, Fengyu Zhang, Ye Yang, Chenchen Liu, Jingmei Xiao, Yujun Long, Jing Huang, Xingjie Peng, Weiyan Wang, Xiaoyi Wang et al. · 2021 · medRxiv
Impact of quetiapine on ion channels and contractile dynamics in rat ventricular myocyte
Orhan Erkan, Nihal Öztürk, Semir Özdemir · 2024 · European Journal of Pharmacology
Extended lifetime expectancy in schizophrenia, role of measurement based care
Lars Helldin, Christine Mohn, Maivor Olsson‐Tall, Iris van Dijk Härd, Anna-Karin Olsson · 2024 · Archives of Psychiatric Nursing
A systematic review of occupation- and activity-based health management interventions for adult patients with severe mental disorders
Elham Nasiri, Ashraf Karbalaei Nouri, Seyed Ali Hosseini, Ghazaleh Mandani · 2025 · Journal of Education and Health Promotion
Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy
Cristiana Perrotta, Carla Carnovale, Marco Pozzi, Clara De Palma, Davide Cervia, Maria Nobile, Emilio Clementi · 2025 · Pharmacological Reviews
From Pharmacological Treatment to Neuromodulation: A Comprehensive Approach to Managing Gilles de la Tourette Syndrome
Edoardo Monfrini, Christian Saleh, Domenico Servello, Phillip Jaszczuk, Mauro Porta · 2025 · International Journal of Molecular Sciences
Incidence and Outcomes of Head and Neck Cancer in Patients With Schizophrenia
Talia A. Wenger, Stephanie J. Wong, Shu‐Yun Cheng, Liyang Tang, Daniel I. Kwon, Niels Kokot, Yang Chai, Uttam K. Sinha, Albert Y. Han · 2025 · OTO Open
Gamified interventions for schizophrenia rehabilitation: A systematic scoping review
Hongyi Yang, Fangyuan Chang, Dian Zhu, Fumie Muroi, Zhao Liu, Weibo Zhang, Jun Cai · 2025 · Clinical Psychology Review
Managing schizophrenia with affective, sexual, metabolic and substance-use comorbidities: pharmacological considerations from an expert consensus
Eduard Vieta, Ángel Montejo, Toby Pillinger, Bernardo Maria Dell’Osso, Maria Dimitraka, Saeed Farooq, Gustavo Jesús, Carlos Parro-Torres, Thomas Wobrock, Sofia Pappa · 2025 · Annals of General Psychiatry
Mechanisms and Clinical Implications of the Post-traumatic Stress Disorder (PTSD)–Cardiovascular Disease Link
Abubakar I Sidik, Vladislav V. Dontsov, Mikhail G Ruchkin, Nina S Kapieva, Bushra M Alimagomaev, Olga S Epimakhova, Nadiya M Toktarova, AMATUNI A. BADOIAN, Anton N Falchinsky, Noemi D Kirkevich et al. · 2025 · Cureus
The effect of olanzapine on lipid profiles in humans: a time and dose response meta-analysis of randomized controlled trials
Fang Zhou, Parmida Jamilian, Mohammad Safargar, Kousalya Prabahar, Shuang Liu · 2026 · BMC Cardiovascular Disorders
Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects: A comparison with prescription dose
Yinzhao Liu, Iris E. Sommer, Georgios Schoretsanitis, Iris M. H. Hamers, Toon Anton Willem Scheurink, Marieke Begemann, Shiral S. Gangadin, Nico J.M. van Beveren, Iris E. Sommer, Lieuwe de Haan et al. · 2026 · European Neuropsychopharmacology
Nutritional Management of Schizophrenia: Gut-Brain Axis Mechanisms and Dietary Interventions
Omid Vakili, Mahsa Motamed, Motahareh Taghizadeh, Seyyed Hossein Khatami · 2026 · Molecular Neurobiology
Decoding psychotropic-induced metabolic disturbances: gut-brain axis, multi-omics, and nutrition-lifestyle integration
Dhoha Dhieb, Kholoud Bastaki · 2026 · Frontiers in Nutrition
Almost all antipsychotics result in weight gain: A meta-analysis
Maarten Bak · 2016 · Journal of Obesity & Weight loss Therapy
Prevalence and Factors Associated With Decreased Bone Mineral Density in Young and Middle-Aged Male Schizophrenic Patients
Yang Shen, Zhiyong Li, Yichen Huang, Jing Yan, Ying Liang · 2017 · Journal of Osteoporosis and Physical Activity
An integrative system biology approach to unravel potential drug candidates for multiple age related disorders
Isha Srivastava, Pooja Khurana, Mohini Yadav, Yasha Hasija · 2017 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Cardiovascular and metabolic side effects of second-generation antipsychotics - narrative review
Przemyslaw Maciej Waszak, Natalia Piskorska, Marta Sarbiewska, Paweł Zagożdżon, Wiesław Jerzy Cubała · 2019 · European Journal of Translational and Clinical Medicine
Distribution of Psychotropic Drugs Into Lipoproteins
Trond Trætteberg Serkland, Jan Didrik Schjøtt, Jon Andsnes Berg, Lars Herfindal, Bettina Riedel, Silje Skrede · 2019 · Therapeutic Drug Monitoring
Psychotropic Polypharmacy among Elderly Patients with Mental Illness in a Malaysian University Hospital: A 10-Year Review of Hospital Databases
Luke Sy‐Cherng Woon · 2021 · Medicine & health
Psychotropic Medications and Heart
Ajay Wagle · 2022 · Open Access Journal of Biomedical Science
Influencing factors of multiple adverse outcomes among schizophrenia patients using count regression models: a cross-sectional study
Lichang Chen, Wenyan Tan, Xiao Lin, Hai-Cheng Lin, Jun‐Yan Xi, Yuqin Zhang, Fu‐Jun Jia, Yuantao Hao · 2022 · BMC Psychiatry
The adverse effects of long-term exposure to antipsychotics among older people with intellectual disabilities: a scoping review
Jemima Turner, Aisling Barry, Jack Doyle, Jane Hogg, Alanna Hynes, Emma Mahon, Cora Moloney, Emma Shortt, Máire O’Dwyer · 2022 · HRB Open Research
Serious Mental Illness, Glycemic Control, and Neighborhood Factors within an Urban Diabetes Cohort
Esti Iturralde, Anna D. Rubinsky, Kim Hanh Nguyen, Chelsie Anderson, Courtney Rees Lyles, Christina V. Mangurian · 2023 · Schizophrenia Bulletin
The impact of educational lifestyle intervention on body weight and psychological health among overweight/obese patients with severe mental disorders
Minzhe Zhang, Jun-xia Shi, Hui Li, Rui Chen, Miaobing Zheng, Li-jing Yan, Neng-jian Wu, Qi‐qiang He · 2023 · Journal of Affective Disorders
Safety of Atypical Antipsychotics in a Child and Adolescent İnpatient Setting: A Naturalistic Study
Burak Baykara, Sevay Alşen Güney, Sibelnur Avcıl, Burçin Şeyda Buran, Remzi Oğulcan Çıray, Çağatay Ermiş, Neslihan İnal · 2024 · Psychiatry and Clinical Psychopharmacology
Effects of antipsychotic drugs during radiotherapy in breast cancer in South Korea: a retrospective cohort study
In Gyu Hwang, Sun Mi Kim, Dae Ryong Kang, Tae‐Hwa Go, Se Hwa Hong, Shin Young Park, Hyunho Lee, Jin Hwa Choi · 2024 · Scientific Reports
Intranasal Insulin Increases Brain Glutathione and Enhances Antioxidant Capacity in Healthy Participants but Not in Those With Early Psychotic Disorders
Virginie‐Anne Chouinard, Wirya Feizi, Xi Chen, Boyu Ren, Kathryn E. Lewandowski, Jacey Anderson, Steven Prete, Emma Tusuzian, Kyle Cuklanz, Shuqin Zhou et al. · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
Lipid disturbances induced by psychotropic drugs: clinical and genetic predictors for early worsening of lipid levels and new-onset dyslipidaemia in Swiss psychiatric samples
Aurélie Delacrétaz, Marie C. Sadler, Franziska Gamma, Martin Preisig, Hélène Richard-Lepouriel, Armin von Gunten, Philippe Conus, Kerstin Jessica Plessen, Zoltán Kutalik, Chin B. Eap · 2024 · BJPsych Open
The prevalence of chronic kidney disease in people with severe mental illness: A systematic review protocol
Claire Carswell, Kate Bramham, Joseph Chilcot, Rowena Jacobs, David Osborn, Najma Siddiqi · 2025 · PLoS ONE
Sicherheitsaspekte bei der Behandlung mit Clozapin
Stefan J. Berger, Alex Hofer · 2023 · Neuropsychiatrie
Weight Gain While Switching from Polypharmacy to Ziprasidone: A Case Report
Chin‐Pang Lee, Alice Pei-Jung Chen, Yeong‐Yuh Juang · 2013 · Clinical Schizophrenia & Related Psychoses
No influence of CYP3A43 rs472660G>A on steady-state serum olanzapine concentrations in White psychiatric patients
Mao Mao Söderberg, Espen Molden, Marja‐Liisa Dahl · 2014 · Pharmacogenetics and Genomics
Long-Term Treatment Strategies for Pediatric Bipolar Disorder
Julia Dorfman, Adelaide S. Robb · 2016 · Current Treatment Options in Psychiatry
Metabolic syndrome in relation to psychotropic polypharmacy
P. Steylen, Frank van der Heijden, H. Kok, N. Sijben, Willem M. A. Verhoeven · 2012 · EUR Research Repository (Erasmus University Rotterdam)
Hyperglycemia Secondary to Nondiabetic Conditions and Therapies
Harold E. Lebovitz · 2010 · Elsevier eBooks
Parents’ Perceptions of the Physical Health Outcomes of Young People Diagnosed with First Episode Psychosis
Gin‐Liang Chee, Dianne Wynaden, Karen Heslop · 2019 · Issues in Mental Health Nursing
Mental Health Nurses' Knowledge of Clozapine
Sujatha Sanjeevi, Angela M. Cocoman · 2020 · Issues in Mental Health Nursing
Evaluation of cardiovascular risk in adult psychiatric outpatients in Qatar using two risk assessment tools
Safa Al-Rawi, Monica Zolezzi, Yassin Hassan Eltorki · 2021 · Qatar medical journal
The Biopsychosocial Model Advanced by Evolutionary Theory
Adam Hunt, Paul St John‐Smith, Riadh Abed · 2021 · Cambridge University Press eBooks
Schizophrenia
BENNO GRAF SCHIMMELMANN, Claudia Mehler‐Wex, Christoph Wewetzer · 2014 · Springer eBooks
Relationship between efficacy and common metabolic parameters in first-treatment drug-naïve patients with early non-response schizophrenia: a retrospective study
Junhong Zhu, Jiajia Wu, Xuebing Liu, Jun Ma · 2023 · Annals of General Psychiatry
Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
Angelo Zinellu, Stefania Sedda, Arduino Aleksander Mangoni · 2023 · Antioxidants
Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study
Xiaofang Chen, Yong Fan, Wenchao Ren, Maodi Sun, Xiaoni Guan, Meihong Xiu, Shuyun Li · 2023 · Frontiers in Pharmacology
A Group-Based, Six-Lesson Healthy Eating Curriculum for Individuals With Serious Mental Illnesses: Development and Implementation
En Fu, Gabriella Farland, Dana E. Cohen, Cheryl Gerstler, Paul J. Margolies, Leah Gogel Pope, Merrill Rotter, Michael T. Compton · 2024 · Community Mental Health Journal
Side Effects of Marketed Drugs: The Utility and Pitfalls of Pharmacovigilance
Steven Whitebread, Mateusz Maciejewski, Alexander Fekete, Eugen Lounkine, László Urbán · 2015 · Methods and principles in medicinal chemistry
PHYSICAL HEALTH CHECKS IN SERIOUS MENTAL ILLNESS: A PROGRAMME OF RESEARCH IN SECONDARY CARE
John White · 2015 · UEA Digital Repository (University of East Anglia)
Differential associations of various depression-related phenotypes with cardiometabolic risks: Identification of shared genetic factors and implications for drug repositioning
Brian Chi‐Fung Wong, Carlos Kwan‐Long Chau, Fu‐Kiu Ao, Cheuk‐Hei Mo, Sze‐Yung Wong, Yui Hang Wong, Hon‐Cheong So · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
Transient parotitis in the course of clozapine treatment: a case report and review of the literature
Koraliya Todorova-Nenova · 2018 · Scripta Scientifica Medica
Risk of dyslipidaemia with antipsychotic drug treatment in Chinese inpatients with mental illness: a hospital-based cohort study
Qiuyue Ma, Fude Yang, Botao Ma, Wenzhan Jing, Jue Liu, Moning Guo, Juan Li, Zhiren Wang, Min Liu · 2021 · BMJ Open
Management Approaches for Behavioural and Psychological Symptoms of Dementia
Maarten J. A. Van Den Bossche, Mathieu Vandenbulcke · 2021 · Springer eBooks
Toxins and the heart
Ryan P. Lau, Michael C. Fishbein · 2022 · Elsevier eBooks
From Fragmentation to Integrated Care
Leopoldo J. Cabassa · 2023
Early adolescent second-generation antipsychotic exposure produces long-term, post-treatment increases in body weight and metabolism-associated gene expression
Paul L. Soto, Michael E. Young, Serena Nguyen, Megan Federoff, Mia M Goodson, Christopher D. Morrison, Heidi M. Batdorf, Susan J. Burke, J. Jason Collier · 2024 · Pharmacology Biochemistry and Behavior
Effectiveness of referral to a population-level telephone coaching service for improving health risk behaviours in people with a mental health condition: a randomised controlled trial
Grace Hanly, Elizabeth M. Campbell, Kate M. Bartlem, Julia Dray, Caitlin M.C. Fehily, Kim Colyvas, Tahlia Reynolds, Sandy Davidson, Sarah Jeong, John Henry Wiggers et al. · 2025 · BMC Public Health
Cardiovascular comorbidities in Chinese inpatients with schizophrenia spectrum disorders
Zhe Dong, Gang Wu, Hongbing Liu, Song Chen, Bin Bi, Fangfang Zhang, Yi Yin, Wei Qu, Baopeng Tian, Fude Yang et al. · 2025 · Schizophrenia
Healthcare Resource Utilization 6 Months Before and After Olanzapine/Samidorphan Initiation: Real-World Assessment of Patients with Schizophrenia or Bipolar I Disorder
Andrew J. Cutler, Hemangi R. Panchmatia, Alejandro G. Hughes, Noah S. Webb, Michael J. Doane, Rakesh Jain · 2025 · Advances in Therapy
Circulating MicroRNAs Are Promising Biomarkers for Assessing the Risk of Antipsychotic-Induced Metabolic Syndrome (Review): Part 2
Natalia Alekseevna Shnayder, Regina Faritovna Nasyrova, N. I. Pekarets, Гречкина Виолетта Владимировна, Марина Михайловна Петрова · 2025 · Safety and Risk of Pharmacotherapy
Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study
Yi-Ting Yeh, Shih‐Chang Lo, Chien‐Ning Huang, Yi‐Sun Yang, Pei‐Lun Liao, Edy Kornelius · 2025 · Frontiers in Pharmacology
Study on disproportionality in the detection of potential signals between quetiapine and diabetic ketoacidosis
Haiya Liang, Dandan Mao, Yan Zhao, Rongjing Zhou · 2025 · European Journal of Clinical Pharmacology
Correlation of Neuroimaging Biomarkers and Pharmacogenetic Profiles in Optimizing Personalized Therapy in Children and Adolescents with Psychotic Disorders
Adriana Cojocaru, Adina Braha, Nicoleta Ioana Andreescu, Alexandra Florina Șerban, Codrina Mihaela Levai, Iulius Jugănaru, Iuliana Costea, Lavinia Hogea, Marius Militaru, Iuliana-Anamaria Trăilă et al. · 2025 · Neurology International
Associations of ANKK1 (rs1800497) polymorphism with glucose and lipid metabolism in patients with schizophrenia treated with olanzapine: a retrospective study
Wenfan Gao, Yayun Xu, Feng Shan, Jun Liang, Qingrong Xia · 2025 · Annals of General Psychiatry
Risk of diabetes mellitus with olanzapine compared to clozapine: A systematic review and meta‐analysis
Keigo Onda, Rizal Ichwansyah, Shuken Boku · 2025 · Psychiatry and Clinical Neurosciences Reports
Health Beyond Symptoms: A Qualitative Study on Perceptions and Meanings of Health and Health Promotion among Individuals with Serious Mental Illness in Community Mental Health Settings
Gesa Pult, Fabian Frank · 2025 · Community Mental Health Journal
Long-term mortality and associated factors in first episode psychosis: a 25-year follow-up study
Chao Li, Wing Tse, Sin Ting Chu, Huiquan Zhou, Charmaine Tsz Wing Wong, Hiu Ching Lim, Christy Lai Ming Hui, Eric Yu Hai Chen, Pak Chung Sham, Hao Luo et al. · 2025 · Psychological Medicine
A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden
Maja Dobrosavljevic, Mikael Landén, Isabell Brikell, Zheng Chang, Ralf Kuja‐Halkola, Paul Lichtenstein, Pontus Andell, Ole A. Andreassen, Michael Bauer, Rosa Corcoy et al. · 2025 · Molecular Psychiatry
Antipsychotic use and associating factors among persons with substance-induced psychosis and first-episode psychotic disorder- A nationwide register-linkage study
Jeyaniroshan Jeyapalan, Heidi T. Taipale, A. Tanskanen, Jari Tiihonen, Ellenor Mittendorfer‐Rutz, Solja Niemelä · 2026 · Schizophrenia Research
Psychiatric disorders associated with increased risk of colorectal cancer in the UK biobank cohort
Zijing Wang, Tingxi Zhu, Litao Huang, Xian Zhang, Xiuhe Lv, X Zhang, Li Yang, David Kerr, Jinlin Yang · 2026 · Scientific Reports
Development and external validation of machine learning approaches for risk prediction of cardiovascular disease in individuals with schizophrenia: a nationwide Swedish and Danish study
Sara Dorthea Nielsen, Maja Dobrosavljevic, Pontus Andell, Zheng Chang, Line Katrine Harder Clemmensen, Henrik Larsson, Michael E. Benros · 2026 · BMJ Mental Health
Monitoring Rates for Metabolic Syndrome in Adults Treated With Atypical Antipsychotics: A Population-Based Study in British Columbia: Fréquence de la surveillance du syndrome métabolique chez les adultes traités par des antipsychotiques atypiques : étude fondée sur la population menée en Colombie-Britannique
Ridhwana Kaoser, Miriam Ruth Lavergne, Sandra Peterson, Agnes Grudniewicz, Helen Thai, Lucie Langford, Rita McCracken, Sara English, David Rudoler · 2026 · The Canadian Journal of Psychiatry
Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension study
Suresh Durgam, Willie R. Earley, Susan G Kozauer, Changzheng Chen, Hassan D. Lakkis, Andrew J. Cutler · 2026 · European Neuropsychopharmacology
Neurobiological mechanisms of second-generation antipsychotic-induced obesity: Interactions between ghrelin signaling and neurotransmitter systems
Nevena S. Zogovic, Ana Despotović, Maja Misirkic-Marjanovic, Ljubica M. Vucicevic, Kristina Janjetović · 2026 · Brain Research Bulletin
Characteristics of Cardiovascular Disease Prediction Models Considering Mental Disorders: A Systematic Review
Sara Siddiqi, Teagan Haggerty, Asia Akther, Simone Rusu, Dawn-Li Blair, Heidi Eccles, Jessica Yu, Risa Shorr, Arnav Gupta, Karen Bouchard et al. · 2026 · Journal of the American Heart Association
Triglyceride-glucose-related indices and cardiovascular disease and mortality among individuals with depression: a prospective study from UK Biobank
Shu-Can Li, Long Xu, Huan Liang, Yuyao Wang, Yue-Ping Shen, Xue Liu · 2026 · Frontiers in Nutrition
Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial
Julia Lappin, Patrick Bolton, Greg Smith, Xin‐Yi Chua, Sarah Grattan, Katherine Samaras, Richard Day, Gordana C. Popovic, Maryanne O׳Donnell, Sara Buten et al. · 2026 · Schizophrenia Research
Lithium‐related adverse drug reactions in children: A case–control study comparing lithium to second‐generation antipsychotics in VigiBase
Lisa T. Ringeling, Ravish N. Gangapersad, Lillian Lieuw, Patrick Cyriel Souverein, Eibert Roelof Heerdink, Pilar García‐Gómez, Manon H. J. Hillegers, Birgit C. P. Koch, Bram Dierckx · 2026 · British Journal of Clinical Pharmacology
Using marginal structural models to identify the cardiovascular adverse effects of second generation antipsychotics in children and adolescents
Avnish Tripathi, George B. Black, Jeanette M. Jerrell · 2015 · Journal of Epidemiological Research
Some side effects and effcts on physical activity of second-generation antipsychotics: A study in children and adolescents
Tahere Sadeghye, Soroor Arman, Reza Bidaki · 2014 · Advanced Biomedical Research
Health behaviour interventions should not neglect people with serious mental health problems
Alison J. Wearden · 2014 · British Journal of Health Psychology
How to Interpret Findings Concerning Newly Approved Antipsychotic Agents
Christoph Ulrich Correll, John Lauriello, ASHOK K. MALLA, Jonathan M. Meyer · 2012 · The Journal of Clinical Psychiatry
When the clock stops ticking, metabolic syndrome explodes. Does omega-3 is able to disarm this bomb?
2014 · Molecular & Cellular Epilepsy
Toxins and the Heart
Michael C. Fishbein · 2015 · Elsevier eBooks
Understanding antipsychotic-induced weight gain and other metabolic issues
Denis Ben Richards, Daniel Thomas Bressington · 2015 · British Journal of Mental Health Nursing
Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia
Nicholas Oh, Yuen Mei See, Gary J. Remington, Jimmy Lee · 2016 · Journal of Clinical Psychopharmacology
Metabolische Nebenwirkungen von Psychopharmaka
René Zeiss, Bernhard J. Connemann, Maximilian Gahr · 2017 · DNP - Der Neurologe und Psychiater
Aspetti psichiatrici del diabete mellito [translation of “Psychiatric aspects of diabetes mellitus” by Mattia Marchi]
Anne Marie Doherty · 2015 · BJPsych Advances